GI therapeutic icon.

Gastrointestinal Virtual Clinical Trials

ObvioHealth’s decentralized study design and user-friendly app break down barriers to traditional GI research.

A GI-related questionnaire asking about the severity of stomach bloating, alongside a questionnaire prompting the user to 'tap each time you experience stomach gas.'

Learn more about our experience in GI clinical research. Speak with our clinical operations team today.

Higher compliance and retention rates are translating to better data for our clients.

Danone logo.

95%

Right Triangle icon.

On our latest pediatric GI study

DSM logo.

86%

Right Triangle icon.

On our latest menopause study

General Mills logo.

92%

Right Triangle icon.

On our latest nutrition study

Mizkan logo.

87%

Right Triangle icon.

On our latest blood pressure study

DTRA Founding Member

As a founding member of DTRA, ObvioHealth is committed to driving the future of decentralized clinical trials in the industry.

Our Client Roster

A. Vogel Logo.
RedHill Biopharma Logo.
Bayer logo.
Glaxo-Smith Kline logo
Danoone Logo.
DSM logo.
entrinsic health logo.
Evolve Biosystems logo
Friesland campina logo.
General mills logo.
Janssen logo.
Lycored logo.
Megafoods logo
mithra logo.
Mizkan logo.
pfizer logo.
Anatara logo.
Renovia Logo.
Left Carousel Arrow icon.
Right carousel arrow icon.

Delivering Better Data for Your GI Study

Recruitment icon.

Recruitment & Onboarding

Recruitment is often a huge barrier to trial success, particularly for GI studies. ObvioHealth uses digital targeting methods to find untapped populations. We identify the online behaviors that point to people with a positive pre-disposition for a specific trial and, because our studies are virtual, we are not geographically tied to a site location.  Data is collected through our proprietary app, giving participants more privacy in their responses.

Once recruited, we enroll participants through virtual prescreening/screening and e-consent. This eliminates the burdensome cost of site retention and staffing requirements, and often shortens the recruitment period.

Data capture icon.

Outcomes Measurement

The ObvioHealth platform and app incorporates multiple data capture technologies to adapt to the needs of any given trial.  These include simple survey-type completion of questionnaires and diaries, image, video and audio capture and use of wearables. Complementary data collection methods ensure more robust data based on real world outcomes.  

Symptoms of GI disorders can be physically uncomfortable, but also quite awkward to discuss with a doctor, leading to fear of embarrassment in face to face interactions. GI study subjects are generally more willing to contribute to research, knowing they can participate from the comfort and discretion of their homes without the burden of traveling to site visits.  

Right Triangle icon.
Compliance icon.

Logistics Management 

Our platform makes it easy to trigger, track and manage products and payment of incentives. ObvioHealth can reimburse participants with the stipend program that is fully virtual. We ship any needed study supplies or devices directly to the participant’s home.

Remote monitoring icon.

Medication Adherence & Adverse Events

An important advantage of ObvioHealth’s app is the real time remote monitoring of medication adherence and potential adverse events. Our escalating system of reminders and immediate AE/SAE detection make our studies safer, while also improving medication adherence.

Right Triangle icon.

Curious if Your GI Study Can Go Virtual?

Free Consultation
ObvioHealth & GI Alliance partnership logo lockup. Text that reads: 'Creating better clinical trial experiences for GI patients'
News category label.

ObvioHealth and GI Alliance Partner to Bring Better GI Care to Patients

ObvioHealth has partnered with GI Alliance, one of the nation's largest independent gastroenterology services organization to facilitate more efficient hybrid clinical trials. This collaboration will make research easier and safer for patients and provide better efficacy data for trial sponsors.

Read Full Case Study
A man consuming a fiber snack bar inside of a gym, post-workout.
GI category label.Nutrition category label.

Evaluating Efficacy and GI Tolerance of Inulin Fiber Bars

A fortune 500 multinational food company wanted to understand clinical efficacy, GI tolerance, and consumer perception of four iterations of its inulin fiber bar. ObvioHealth virtually recruited, randomized, shipped and captured data across 4 samples in record time.

• 85% questionnaire compliance
• 92% retention

Read Full Case Study

Therapeutic Areas

ObvioHealth has conducted 42 studies in 28 countries with more than 25,000 participants. Click through the therapeutic areas below to see some of our case studies.

Virtual Trial Journey

A Seamless End-to-End Experience

ObvioHealth studies are run on our purpose-built platform by our own in-house virtual team. This allows us to work seamlessly from protocol design all the way through to analysis and reporting.

Higher compliance, higher retention, more accurate data

Free Consultation